By Fiona Soltes
The recent season has provided us all a rich opportunity for new vision, new focus, and new emphasis on what’s truly important. The National Hemophilia Foundation is of like mind.
NHF leaders officially commenced the 2021 Bleeding Disorders Conference with the Wednesday afternoon BDC Opening Session, a plenary that explored fresh goals and energy for the organization and the bleeding disorders community.
First up: research.
“NHF has always been about education, advocacy and research,” said Leonard Valentino, MD, NHF president and CEO. “But we thought it was important to refocus our mission to bring research to the forefront. We’re embarking on a course to create a national research agenda through community input, including the voice of the patient.”
Story continues here...
By Deb Burrows, BS, MA, EMTP
NHF President and CEO Leonard Valentino, MD, opened COVID-19: What's Now, What's Next, by thanking attendees for joining the virtual presentation. He introduced speakers Katelyn Jetelina, MPH, PhD, University of Texas Health Science Center at Houston, and Scott Kaatz, DO, Wayne State University.
Jetelina began the conversation by speaking to the current epidemiological research surrounding COVID-19.
“We are clearly in our fourth wave of the pandemic,” Jetelina said. “We have a very uneven spread with most transmissions in the South.” States seeing the most new confirmed cases include Mississippi, Florida and Alabama. The Delta variant is responsible for 96 percent of cases in the United States.